48.47
price up icon0.12%   0.06
after-market 시간 외 거래: 48.47
loading

Grail Inc 주식(GRAL)의 최신 뉴스

pulisher
Mar 19, 2026

GRAIL, Inc. Opens with 5.11% Gain, Outperforming S&P 500's 1.01% Rise - Markets Mojo

Mar 19, 2026
pulisher
Mar 19, 2026

The Escalator: Biogen, Flagship Pioneering, Grail and more - Medical Marketing and Media

Mar 19, 2026
pulisher
Mar 18, 2026

Grail stock jumps after TD Cowen upgrade on cancer test outlook - Investing.com Canada

Mar 18, 2026
pulisher
Mar 18, 2026

Grail slides as trial misses primary endpoint, fails to show significant stage III-IV cancer reduction - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

GRAIL outlines 2025 commercial growth plans and targets up to 30% US Galleri revenue increase - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Grail stock jumps after TD Cowen upgrade on cancer test outlook By Investing.com - Investing.com Australia

Mar 18, 2026
pulisher
Mar 18, 2026

Grail stock upgraded at TD Cowen after selloff (GRAL:NASDAQ) - Seeking Alpha

Mar 18, 2026
pulisher
Mar 18, 2026

GRAIL (NASDAQ:GRAL) Trading Up 6.9% Following Analyst Upgrade - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Here’s what analysts are saying about Grail Inc. (GRAL) - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED - PR Newswire

Mar 18, 2026
pulisher
Mar 18, 2026

GRAIL (NASDAQ:GRAL) Raised to Buy at TD Cowen - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

TD Cowen upgrades Grail stock rating to buy on cancer detection market potential - Investing.com

Mar 18, 2026
pulisher
Mar 17, 2026

GRAIL, Inc. (NASDAQ:GRAL) Sees Significant Increase in Short Interest - MarketBeat

Mar 17, 2026
pulisher
Mar 16, 2026

Does GRAIL (GRAL) Elevating Josh Ofman to CEO Reframe Its Management Quality Narrative? - simplywall.st

Mar 16, 2026
pulisher
Mar 16, 2026

GRAIL names Josh Ofman as CEO, Bob Ragusa to retire June 1 - Investing.com Nigeria

Mar 16, 2026
pulisher
Mar 16, 2026

Grail CEO Bob Ragusa to retire - MedTech Dive

Mar 16, 2026
pulisher
Mar 16, 2026

Farallon Capital Management LLC Buys 847,000 Shares of GRAIL, Inc. $GRAL - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

GRAIL, Inc. (NASDAQ:GRAL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Is GRAIL’s Research Platform Drawing Biotechnology Attention? - Kalkine Media

Mar 16, 2026
pulisher
Mar 15, 2026

GRAIL2026 Funding Rounds & List of Investors - Tracxn

Mar 15, 2026
pulisher
Mar 15, 2026

GRAIL announces leadership transition - MSN

Mar 15, 2026
pulisher
Mar 14, 2026

Assessing GRAIL (GRAL) Valuation After Recent Share Price Pullback And Ongoing Growth Challenges - Yahoo Finance

Mar 14, 2026
pulisher
Mar 14, 2026

Canaccord Genuity Reaffirms Their Buy Rating on GRAIL Inc (GRAL) - The Globe and Mail

Mar 14, 2026
pulisher
Mar 13, 2026

GRAIL Inc (GRAL) Shares Down 4.59% on Mar 13 - GuruFocus

Mar 13, 2026
pulisher
Mar 13, 2026

Assessing GRAIL (GRAL) Valuation After Recent Share Price Volatility and Narrative Fair Value Gap - simplywall.st

Mar 13, 2026
pulisher
Mar 13, 2026

Grail Inc. Announces CEO Transition - Contract Pharma

Mar 13, 2026
pulisher
Mar 13, 2026

Grail CEO to retire after failed cancer detection trialSan Francisco Business Times - The Business Journals

Mar 13, 2026
pulisher
Mar 12, 2026

GRAIL, Inc. Hits Day High with 12.18% Surge Amid Market Challenges - Markets Mojo

Mar 12, 2026
pulisher
Mar 12, 2026

(GRAL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 12, 2026

Freidin, Grail CFO, sells $154k in GRAL stock - Investing.com Nigeria

Mar 12, 2026
pulisher
Mar 12, 2026

Grail CEO Bob Ragusa retiring, Josh Ofman appointed successor - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

GRAIL, Inc. 2025 Annual Report: Multi-Cancer Early Detection with Galleri, Company Strategy, and Key Business Risks - Minichart

Mar 12, 2026
pulisher
Mar 12, 2026

GRAIL, Inc. Announces Chief Executive Officer Changes, Effective June 1, 2026 - marketscreener.com

Mar 12, 2026
pulisher
Mar 12, 2026

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor - Carroll County Mirror-Democrat

Mar 12, 2026
pulisher
Mar 12, 2026

Levi & Korsinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed - marketscreener.com

Mar 12, 2026
pulisher
Mar 11, 2026

Here's Why Grail Shares Crashed in February and Why it Could Be a Buying Opportunity - AOL.com

Mar 11, 2026
pulisher
Mar 10, 2026

Grail Inc’s Earnings Call Balances Momentum and Risk - TipRanks

Mar 10, 2026
pulisher
Mar 10, 2026

A Persistent Patient’s Story - RealClearHealth

Mar 10, 2026
pulisher
Mar 10, 2026

Archaeopteryx | The Holy Grail of Fossils at the Field Museum - Britannica

Mar 10, 2026
pulisher
Mar 09, 2026

GRAIL (NASDAQ:GRAL) CEO Sells $51,949.80 in Stock - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Aaron Freidin Sells 2,492 Shares of GRAIL (NASDAQ:GRAL) Stock - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Joshua Ofman Sells 2,937 Shares of GRAIL (NASDAQ:GRAL) Stock - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

GRAIL (NASDAQ:GRAL) CFO Aaron Freidin Sells 655 Shares - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Insider Selling: GRAIL (NASDAQ:GRAL) CEO Sells 7,461 Shares of Stock - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Freidin, Grail CFO, sells $154k in GRAL stock By Investing.com - Investing.com Australia

Mar 09, 2026
pulisher
Mar 09, 2026

Ofman Joshua J. (GRAIL) sells $177k in shares - Investing.com South Africa

Mar 09, 2026
pulisher
Mar 09, 2026

Grail CEO Ragusa sells $409k in shares - Investing.com India

Mar 09, 2026
pulisher
Mar 09, 2026

CFO at GRAIL (GRAL) executes 3,147-share automatic sell-to-cover - Stock Titan

Mar 09, 2026
pulisher
Mar 09, 2026

GRAIL (NASDAQ: GRAL) CEO logs 8,441-share sale for tax withholding - Stock Titan

Mar 09, 2026
diagnostics_research DGX
$194.16
price down icon 0.55%
diagnostics_research LH
$264.09
price down icon 0.66%
diagnostics_research MTD
$1,190.49
price down icon 0.09%
diagnostics_research IQV
$166.47
price down icon 0.33%
$202.73
price up icon 2.50%
diagnostics_research WAT
$299.57
price up icon 1.53%
자본화:     |  볼륨(24시간):